Advisory Research’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $342K | Buy |
14,898
+1,009
| +7% | +$23.2K | 0.05% | 130 |
|
|
2025
Q1 | $403K | Buy |
13,889
+36
| +0.3% | +$1.04K | 0.07% | 138 |
|
|
2024
Q4 | $514K | Buy |
13,853
+43
| +0.3% | +$1.6K | 0.09% | 134 |
|
|
2024
Q3 | $670K | Sell |
13,810
-460
| -3% | -$22.3K | 0.12% | 125 |
|
|
2024
Q2 | $571K | Buy |
14,270
+941
| +7% | +$37.6K | 0.11% | 132 |
|
|
2024
Q1 | $585K | Sell |
13,329
-845
| -6% | -$37.1K | 0.12% | 125 |
|
|
2023
Q4 | $877K | Sell |
14,174
-716
| -5% | -$44.3K | 0.14% | 175 |
|
|
2023
Q3 | $685K | Sell |
14,890
-517
| -3% | -$23.8K | 0.1% | 235 |
|
|
2023
Q2 | $885K | Buy |
15,407
+628
| +4% | +$36.1K | 0.11% | 218 |
|
|
2023
Q1 | $554K | Buy |
+14,779
| New | +$554K | 0.09% | 233 |
|
|
2022
Q4 | – | Sell |
-15,148
| Closed | -$426K | – | 367 |
|
|
2022
Q3 | $426K | Buy |
+15,148
| New | +$426K | 0.04% | 252 |
|